Beruflich Dokumente
Kultur Dokumente
and then again at 24 weeks after stopping treatment (sustained viral response). Although no difference was observed between the two groups at four weeks, the researchers found considerable differences in response at all other time points, particularly 24 weeks after stopping treatment. In addition, they found that patients who carried the type 1 strain responded significantly better than patients who carried the type 2 or 3 strain. Results from the study indicated that adding vitamin B12 supplements to standard therapy increased the rate of sustained viral response by 34%. The researchers state that adding vitamin B12 to standard therapy is a safe and cheap alternative to new generation antiviral drugs, especially for patients who carry the type 1 strain. The researchers note: "This strategy would be especially useful in those countries where, owing to limited economic means, the new generation antiviral therapies cannot be given in routine practice." Written by Grace Rattue Copyright: Medical News Today Article Date: 18 Jul 2012 - 9:00 PDT SOURCE: http://www.medicalnewstoday.com/articles/247986.php
SUMMARY: My journal is all about the study/research about patients with chronic hepatitis C who is receiving standard HCV treatment may benefit from taking vitamin B12. According to the study conducted that taking in vitamin B12 supplements could boost the bodys ability to fight the virus. The study was conducted to persons to patients whose infection was difficult to treat